Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Uncommon Manifestation of Oligometastatic Prostate Cancer: Sister Mary Joseph Nodule.
Journal: Clinical nuclear medicine
Published: March 07, 2023
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial.
Journal: Journal for immunotherapy of cancer
Published: January 14, 2022
Role of DNA Methylation in Cabazitaxel Resistance in Prostate Cancer.
Journal: Anticancer research
Published: January 02, 2016
Prognostic significance of cystoscopy findings following neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Journal: The Canadian journal of urology
Published: April 21, 2015
Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy.
Journal: Clinical genitourinary cancer
Published: June 17, 2014
Free circulating DNA as a biomarker of prostate cancer: comparison of quantitation methods.
Journal: Anticancer research
Published: October 15, 2013
Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completion.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India
Published: March 02, 2013
5-azacytidine reverses drug resistance in bladder cancer cells.
Journal: Anticancer research
Published: November 24, 2011
Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk.
Journal: Oncology reports
Published: July 14, 2005
Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk.
Journal: International journal of oncology
Published: October 20, 2004
Last Updated: 09/26/2026